What is the price target for IBIO stock?
12 analysts have analysed IBIO and the average price target is 5.47 USD. This implies a price increase of 159.43% is expected in the next year compared to the current price of 2.11.
IBIO INC (IBIO) Forecast, Price Target & Analyst Ratings
NASDAQ:IBIO • US4510337086
Current stock price
2.11 USD
+0.08 (+3.94%)
At close:
2.145 USD
+0.04 (+1.66%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IBIO INC (IBIO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.06
- Revenue Estimate
- 20.4K
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.47
Upside
+ 159.43%
From current price of $2.11 to mean target of $5.47, Based on 12 analyst forecasts
Low
$4.24
Median
$5.10
High
$7.35
Price Target Revisions
1 Month
18.73%
3 Months
21.97%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for IBIO. The average price target is 5.47 USD. This implies a price increase of 159.43% is expected in the next year compared to the current price of 2.11.
The average price target has been revised upward by 21.97% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
IBIO was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IBIO.
In the previous month the buy percentage consensus was at a similar level.
IBIO was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-03-03 | Jones Trading | Initiate | Buy |
| 2026-02-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-21 | Oppenheimer | Initiate | Outperform |
| 2025-10-17 | Leerink Partners | Initiate | Outperform |
| 2025-06-25 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-17 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2024-07-22 | Brookline Capital | Initiate | Buy |
| 2024-06-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-28 | Chardan Capital | Initiate | Buy |
| 2023-02-16 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-10-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2021-11-29 | JMP Securities | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q3 / 2026
- EPS Estimate
- -$0.06
- Revenue Estimate
- 20.4K
- Revenue Q2Q
- N/A
- EPS Q2Q
- 86.95%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
-20.00%
Revenue (3 Months)
-39.99%
EPS (1 Month)
0.84%
EPS (3 Months)
-10.59%
Next Earnings Summary
IBIO is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 20.40K USD.
The next earnings revenue estimate has been revised downward by 39.99% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 225K | 400K 77.78% | 183.6K -54.10% | 102K -44.44% | 170.003K 66.67% | 255K 50.00% | 255K | 255K | 22.185M 8,600.00% | 165.6M 646.45% | |
| EBITDA YoY % growth | -27.74M -12.44% | -15.705M 43.39% | -17.827M -13.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.77M -2.97% | -16.634M 42.18% | -18.602M -11.83% | -30.717M -65.13% | -46.823M -52.43% | -63.877M -36.42% | -62.77M 1.73% | -74.619M -18.88% | -89.167M -19.50% | -97.101M -8.90% | N/A | |
| Operating Margin | N/A | -7,392.89% | -4,650.50% | -16,730.28% | -45,904.75% | -37,574.10% | -24,615.60% | -29,262.40% | -34,967.60% | -437.69% | N/A | |
| EPS YoY % growth | -115.20 -0.88% | N/A 93.44% | -1.92 74.60% | -0.31 83.78% | -0.30 2.70% | -0.44 -46.30% | -0.60 -35.79% | -0.59 1.69% | -0.43 27.59% | -0.22 47.62% | 0.07 131.82% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 86.95% | -0.06 87.03% | -0.09 21.18% | -0.08 15.00% | -0.08 -19.67% | -0.08 -20.33% |
| Revenue Q2Q % growth | 20.4K | 61.2K -69.40% | -100.00% | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.286M -49.33% | -8.031M -54.51% | -9.18M -54.26% | -9.18M 2.81% | -9.18M -26.00% | -8.67M -7.95% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.95%
EPS Next 5 Year
11.09%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-5.90%
Revenue Next 5 Year
4.56%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IBIO INC / IBIO Forecast FAQ
What is the next earnings date for IBIO stock?
IBIO INC (IBIO) will report earnings on 2026-04-30.
What are the consensus estimates for IBIO stock next earnings?
The consensus EPS estimate for the next earnings of IBIO INC (IBIO) is -0.06 USD and the consensus revenue estimate is 20.40K USD.
Can you provide the expected long term growth rate for IBIO INC stock?
The expected long term growth rate for IBIO INC (IBIO) is -5.9%.